I stopped taking 10mg of Methotrexate in April and it has been half a year since I switched to Metoject. Although I have ...
A comprehensive scientific review evaluates how multifunctional smart hydrogels combine localized anticancer therapy with ...
Two randomized phase III clinical trials demonstrate that the biosimilar GP2015 achieves equivalent quality-of-life and ...
Approval based on Phase 3 NIMBLE results demonstrating rapid, deep and sustained disease control that is maintained throughout three-month dosing intervals Livsayis is Regeneron's first approved siRNA ...
Supported by phase 3 PREVAIL data, the dual-binding nanobody complement C5 inhibitor provides rapid, sustained functional ...
The once weekly self-injected treatment is the first dual-binding nanobody C5 inhibitor approved for adults with AChR ...
Compare oral pills, weekly injections, and infusions for immune thrombocytopenia (ITP) treatment, including pros, cons, ...
Chronic alcohol use is a risk factor for some cancers and can impair the immune response to infections. Gilley et al. found ...